Pressbaum, Austria

Urban Lunberg

This inventor holds 1 USPTO granted patent. Top assignee: Valneva Se. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Urban Lunberg. Retrieved from https://idiyas.com/inventor/urban-lunberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Urban Lunberg: Innovator in Pharmaceutical Compositions

Introduction

Urban Lunberg is a notable inventor based in Pressbaum, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immunogenic compositions.

Latest Patents

Urban Lunberg holds a patent for a method of producing pharmaceutical compositions comprising the immunogenic Chikungunya virus CHIKV-Delta5nsP3. This invention relates to a process for producing a live attenuated Chikungunya virus, as well as pharmaceutical compositions that include this virus.

Career Highlights

Urban Lunberg is currently associated with Valneva SE, a company focused on developing and commercializing innovative vaccines. His work in this organization has been pivotal in advancing vaccine technology.

Collaborations

Some of Urban Lunberg's coworkers include Andrea Fritzer and Andreas Meinke, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Urban Lunberg's innovative work in pharmaceutical compositions showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…